The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis

2020205 citationsReviewgold Open Access

Authors

Aref Shariati · Iran University of Medical Sciences

Masoud Dadashi · Alborz University of Medical Sciences

Zahra Chegini · Iran University of Medical Sciences

Alex van Belkum

Mehdi Mirzaii · Shahroud University of Medical Sciences

Seyed Sajjad Khoramrooz · Yasuj University of Medical Sciences

Davood Darban‐Sarokhalil · Iran University of Medical Sciences

Abstract

The present study shows that resistance to new agents is low in staphylococci and these antibiotics can still be used for treatment of staphylococcal infections in the world.

Topics & Keywords

Antimicrobial Resistance in Staphylococcus Bacterial Identification and Susceptibility Testing Bacterial biofilms and quorum sensing

Publication Details

Published in: Antimicrobial Resistance and Infection Control

Volume 9, Issue 1, pp. 56-56

DOI: 10.1186/s13756-020-00714-9

Field-Weighted Citation Impact: 2.51

Command Palette

The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase–negative staphylococci strains: a systematic review and meta-analysis

Authors

Abstract

Topics & Keywords

Publication Details